Cargando…
Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms
Central Core Disease (CCD) is a genetic neuromuscular disorder characterized by the presence of cores in muscle biopsy. The inheritance has been described as predominantly autosomal dominant (AD), and the disease may present as severe neonatal or mild adult forms. Here we report clinical and molecul...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141459/ https://www.ncbi.nlm.nih.gov/pubmed/35627144 http://dx.doi.org/10.3390/genes13050760 |
_version_ | 1784715351374692352 |
---|---|
author | Cotta, Ana Souza, Lucas Santos Carvalho, Elmano Feitosa, Leticia Nogueira Cunha, Antonio Navarro, Monica Machado Valicek, Jaquelin Menezes, Miriam Melo Neves, Simone Vilela Nunes Xavier-Neto, Rafael Vargas, Antonio Pedro Takata, Reinaldo Issao Paim, Julia Filardi Vainzof, Mariz |
author_facet | Cotta, Ana Souza, Lucas Santos Carvalho, Elmano Feitosa, Leticia Nogueira Cunha, Antonio Navarro, Monica Machado Valicek, Jaquelin Menezes, Miriam Melo Neves, Simone Vilela Nunes Xavier-Neto, Rafael Vargas, Antonio Pedro Takata, Reinaldo Issao Paim, Julia Filardi Vainzof, Mariz |
author_sort | Cotta, Ana |
collection | PubMed |
description | Central Core Disease (CCD) is a genetic neuromuscular disorder characterized by the presence of cores in muscle biopsy. The inheritance has been described as predominantly autosomal dominant (AD), and the disease may present as severe neonatal or mild adult forms. Here we report clinical and molecular data on a large cohort of Brazilian CCD patients, including a retrospective clinical analysis and molecular screening for RYR1 variants using Next-Generation Sequencing (NGS). We analyzed 27 patients from 19 unrelated families: four families (11 patients) with autosomal dominant inheritance (AD), two families (3 patients) with autosomal recessive (AR), and 13 sporadic cases. Biallelic RYR1 variants were found in six families (two AR and four sporadic cases) of the 14 molecularly analyzed families (~43%), suggesting a higher frequency of AR inheritance than expected. None of these cases presented a severe phenotype. Facial weakness was more common in biallelic than in monoallelic patients (p = 0.0043) and might be a marker for AR forms. NGS is highly effective for the identification of RYR1 variants in CCD patients, allowing the discovery of a higher proportion of AR cases with biallelic mutations. These data have important implications for the genetic counseling of the families. |
format | Online Article Text |
id | pubmed-9141459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91414592022-05-28 Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms Cotta, Ana Souza, Lucas Santos Carvalho, Elmano Feitosa, Leticia Nogueira Cunha, Antonio Navarro, Monica Machado Valicek, Jaquelin Menezes, Miriam Melo Neves, Simone Vilela Nunes Xavier-Neto, Rafael Vargas, Antonio Pedro Takata, Reinaldo Issao Paim, Julia Filardi Vainzof, Mariz Genes (Basel) Article Central Core Disease (CCD) is a genetic neuromuscular disorder characterized by the presence of cores in muscle biopsy. The inheritance has been described as predominantly autosomal dominant (AD), and the disease may present as severe neonatal or mild adult forms. Here we report clinical and molecular data on a large cohort of Brazilian CCD patients, including a retrospective clinical analysis and molecular screening for RYR1 variants using Next-Generation Sequencing (NGS). We analyzed 27 patients from 19 unrelated families: four families (11 patients) with autosomal dominant inheritance (AD), two families (3 patients) with autosomal recessive (AR), and 13 sporadic cases. Biallelic RYR1 variants were found in six families (two AR and four sporadic cases) of the 14 molecularly analyzed families (~43%), suggesting a higher frequency of AR inheritance than expected. None of these cases presented a severe phenotype. Facial weakness was more common in biallelic than in monoallelic patients (p = 0.0043) and might be a marker for AR forms. NGS is highly effective for the identification of RYR1 variants in CCD patients, allowing the discovery of a higher proportion of AR cases with biallelic mutations. These data have important implications for the genetic counseling of the families. MDPI 2022-04-26 /pmc/articles/PMC9141459/ /pubmed/35627144 http://dx.doi.org/10.3390/genes13050760 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cotta, Ana Souza, Lucas Santos Carvalho, Elmano Feitosa, Leticia Nogueira Cunha, Antonio Navarro, Monica Machado Valicek, Jaquelin Menezes, Miriam Melo Neves, Simone Vilela Nunes Xavier-Neto, Rafael Vargas, Antonio Pedro Takata, Reinaldo Issao Paim, Julia Filardi Vainzof, Mariz Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms |
title | Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms |
title_full | Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms |
title_fullStr | Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms |
title_full_unstemmed | Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms |
title_short | Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms |
title_sort | central core disease: facial weakness differentiating biallelic from monoallelic forms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141459/ https://www.ncbi.nlm.nih.gov/pubmed/35627144 http://dx.doi.org/10.3390/genes13050760 |
work_keys_str_mv | AT cottaana centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT souzalucassantos centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT carvalhoelmano centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT feitosaleticianogueira centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT cunhaantonio centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT navarromonicamachado centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT valicekjaquelin centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT menezesmiriammelo centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT nevessimonevilelanunes centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT xaviernetorafael centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT vargasantoniopedro centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT takatareinaldoissao centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT paimjuliafilardi centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms AT vainzofmariz centralcorediseasefacialweaknessdifferentiatingbiallelicfrommonoallelicforms |